EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy and safety of narrowband ultraviolet B versus combined ultraviolet A/narrowband ultraviolet B phototherapy in the treatment of chronic atopic dermatitis: A randomised double‐blind study

Rayson Rui Sheng Lee iD, Sophie Carrie-Shan Cai, Yisheng Wong, Yik Weng Yew, Hazel H Oon iD, Wei-Sheng Chong, Hong Liang Tey, Eugene Sern-Ting Tan

Experimental Dermatology · 2024

DOI: 10.1111/exd.15012 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Rayson Rui Sheng Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Skin Centre, Singapore, Singapore. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Ultraviolet Therapy, Eczema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phototherapy is a useful treatment modality for atopic dermatitis (AD). This is a prospective randomised double‐blind study comparing the clinical efficacy of combined ultraviolet‐A (UVA)/narrowband ultraviolet‐B (NBUVB) versus NBUVB phototherapy in the treatment of chronic AD. Patients with moderate‐to‐severe AD were randomised to receive either UVA/NBUVB or NBUVB phototherapy twice weekly over 12 weeks. At baseline, weeks 6 and 12, Eczema Area And Severity Index (EASI), itch score and adverse effects were assessed. At baseline and week 12, disease‐related quality of life was evaluated using the Dermatology Life Quality Index (DLQI). Nine patients were randomised to receive UVA/NBUVB and 10 received NBUVB. At week 12, both groups showed significant improvement in EASI and itch scores ( p < 0.05). Significant improvement in DLQI was seen in the UVA/NBUVB arm ( p = 0.009) with a trend towards improvement in the NBUVB arm ( p = 0.11). The efficacy of both modalities were comparable, as were reported adverse effects aside from skin dryness which was higher in the NBUVB arm (40% vs. 0%, p = 0.033). Combined UVA/NBUVB and NBUVB phototherapy have comparable clinical efficacy and safety in the treatment of chronic AD. NBUVB may induce greater skin dryness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicUltraviolet TherapyEczemaHumansProspective StudiesDouble-Blind MethodQuality of LifePhototherapyPruritusTreatment Outcome

Stichwörter der Autor:innen

NBUVBUVA/NBUVBUVABatopic dermatitiseczemaphototherapy

Autor:innen und Institutionen

  • National Skin Centre, Singapore, Singapore.
  • Tan Tock Seng Hospital, Singapore, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

ORCID-Profile: Rayson Rui Sheng Lee, Hazel H Oon

Zitieren

APA

Lee, R. R. S., Cai, S. C., Wong, Y., Yew, Y. W., Oon, H. H., Chong, W. S., Tey, H. L., & Tan, E. S. (2024). Efficacy and safety of narrowband ultraviolet B versus combined ultraviolet A/narrowband ultraviolet B phototherapy in the treatment of chronic atopic dermatitis: A randomised double‐blind study. Experimental Dermatology. https://doi.org/10.1111/exd.15012

Vancouver

Lee RRS, Cai SC, Wong Y, Yew YW, Oon HH, Chong WS, et al. Efficacy and safety of narrowband ultraviolet B versus combined ultraviolet A/narrowband ultraviolet B phototherapy in the treatment of chronic atopic dermatitis: A randomised double‐blind study. Experimental Dermatology. 2024. doi:10.1111/exd.15012

BibTeX
@article{Lee2024,
  author = {Lee, Rayson Rui Sheng and Cai, Sophie Carrie-Shan and Wong, Yisheng and Yew, Yik Weng and Oon, Hazel H and Chong, Wei-Sheng and Tey, Hong Liang and Tan, Eugene Sern-Ting},
  title = {Efficacy and safety of narrowband ultraviolet B versus combined ultraviolet A/narrowband ultraviolet B phototherapy in the treatment of chronic atopic dermatitis: A randomised double‐blind study},
  journal = {Experimental Dermatology},
  year = {2024},
  doi = {10.1111/exd.15012}
}
Kostenlos starten →